Cargando…
Reducing the Fatality Rate of COVID-19 by Applying Clinical Insights From Immuno-Oncology and Lung Transplantation
There is an urgent need to identify effective strategies that can stop or reverse the inflammatory process that causes acute lung injury, ARDS, and multi-organ failure in COVID-19. Adaptive clinical trials with parallel enrollment to different arms each evaluating a rationally designed combination m...
Autor principal: | Uckun, Fatih M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264370/ https://www.ncbi.nlm.nih.gov/pubmed/32574237 http://dx.doi.org/10.3389/fphar.2020.00796 |
Ejemplares similares
-
Editorial: Coronavirus disease (COVID-19): mechanistic basic, translational, and clinical research aimed at identification of effective preventive and therapeutic strategies
por: Montuschi, Paolo, et al.
Publicado: (2023) -
TCMIO: A Comprehensive Database of Traditional Chinese Medicine on Immuno-Oncology
por: Liu, Zhihong, et al.
Publicado: (2020) -
Repurposing Anti-Malaria Phytomedicine Artemisinin as a COVID-19 Drug
por: Uckun, Fatih M., et al.
Publicado: (2021) -
Immuno-Positron Emission Tomography with Zirconium-89-Labeled Monoclonal Antibodies in Oncology: What Can We Learn from Initial Clinical Trials?
por: Jauw, Yvonne W. S., et al.
Publicado: (2016) -
Immuno-Oncology
por: Chaudhuri, Swapna
Publicado: (2017)